Screener
Lipocine LPCN Q3 2025 earnings
Reported November 6, 2025 · Before market open
Revenue$114.6KMiss by $123.4K
EPS-$0.59Miss by $0.03
Revenue estimate$238.0K
EPS estimate-$0.56
Next report
Nov 5, 2026 (in a month)Revenue estimate$159.5K
EPS estimate-$0.39
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Lipocine report Q3 2025 earnings?
- Lipocine (LPCN) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were Lipocine's Q3 2025 revenue and EPS?
- Lipocine reported revenue of $114.6K and eps of $-0.59 for Q3 2025.
- Did Lipocine beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $238.0K by $123.4K. EPS missed the consensus estimate of $-0.56 by $0.03.
- How did Lipocine's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 34.1% from $-0.44.
- Where can I find Lipocine's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-25-020677) and the 10-Q periodic report (0001493152-25-021007) directly on SEC EDGAR. The filing index links above go to sec.gov.
